Assessment of disease activity in large-vessel vasculitis: Results of an international delphi exercise

International Delphi on Disease Activity Assessment in Large-vessel Vasculitis

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Objective. To arrive at consensus for candidate outcomes for disease activity assessment in largevessel vasculitis (LVV) in clinical trials. Methods.A Delphi survey including 99 items was circulated among international experts for 3 rounds. Results. Fifty-seven items were accepted for both giant cell arteritis and Takayasu arteritis. Sixty-seven percent of experts voted to have a common approach for both diseases with additional disease-specific items such as weight loss, scalp tenderness/necrosis, morning stiffness, dizziness, visual symptoms, and imaging. Conclusion. This study highlights similarities and differences in experts' perspectives for assessing clinical activity in LVV and may guide a consensus-driven core set of validated outcomes.

Original languageEnglish (US)
Pages (from-to)1928-1932
Number of pages5
JournalJournal of Rheumatology
Volume44
Issue number12
DOIs
StatePublished - Dec 1 2017

Fingerprint

Vasculitis
Takayasu Arteritis
Giant Cell Arteritis
Dizziness
Scalp
Weight Loss
Necrosis
Clinical Trials

Keywords

  • Giant cell arteritis
  • Large vessel
  • Outcomes
  • Takayasu arteritis
  • Vasculitis

ASJC Scopus subject areas

  • Rheumatology
  • Immunology and Allergy
  • Immunology

Cite this

International Delphi on Disease Activity Assessment in Large-vessel Vasculitis (2017). Assessment of disease activity in large-vessel vasculitis: Results of an international delphi exercise. Journal of Rheumatology, 44(12), 1928-1932. https://doi.org/10.3899/jrheum.161269

Assessment of disease activity in large-vessel vasculitis : Results of an international delphi exercise. / International Delphi on Disease Activity Assessment in Large-vessel Vasculitis.

In: Journal of Rheumatology, Vol. 44, No. 12, 01.12.2017, p. 1928-1932.

Research output: Contribution to journalArticle

International Delphi on Disease Activity Assessment in Large-vessel Vasculitis 2017, 'Assessment of disease activity in large-vessel vasculitis: Results of an international delphi exercise', Journal of Rheumatology, vol. 44, no. 12, pp. 1928-1932. https://doi.org/10.3899/jrheum.161269
International Delphi on Disease Activity Assessment in Large-vessel Vasculitis. Assessment of disease activity in large-vessel vasculitis: Results of an international delphi exercise. Journal of Rheumatology. 2017 Dec 1;44(12):1928-1932. https://doi.org/10.3899/jrheum.161269
International Delphi on Disease Activity Assessment in Large-vessel Vasculitis. / Assessment of disease activity in large-vessel vasculitis : Results of an international delphi exercise. In: Journal of Rheumatology. 2017 ; Vol. 44, No. 12. pp. 1928-1932.
@article{2087937afae24812a239cea02bc8a786,
title = "Assessment of disease activity in large-vessel vasculitis: Results of an international delphi exercise",
abstract = "Objective. To arrive at consensus for candidate outcomes for disease activity assessment in largevessel vasculitis (LVV) in clinical trials. Methods.A Delphi survey including 99 items was circulated among international experts for 3 rounds. Results. Fifty-seven items were accepted for both giant cell arteritis and Takayasu arteritis. Sixty-seven percent of experts voted to have a common approach for both diseases with additional disease-specific items such as weight loss, scalp tenderness/necrosis, morning stiffness, dizziness, visual symptoms, and imaging. Conclusion. This study highlights similarities and differences in experts' perspectives for assessing clinical activity in LVV and may guide a consensus-driven core set of validated outcomes.",
keywords = "Giant cell arteritis, Large vessel, Outcomes, Takayasu arteritis, Vasculitis",
author = "{International Delphi on Disease Activity Assessment in Large-vessel Vasculitis} and Aydin, {Sibel Z.} and Haner Direskeneli and Merkel, {Peter A.} and Sergio Toloza and Daniel Blockmans and Sato, {Emilia Inoue} and {De Souza}, {Alexandre Wagner Silva} and David Cabral and Simon Carette and Leilani Famorca and Nader Khalidi and Nataliya Milman and Elaine Yacyshyn and Vladimir Tesar and Bo Baslund and Mikkel Faurschou and Lo{\"i}c Guillevin and Xavier Pu{\'e}chal and Peer Aries and Bernhard Hellmich and Karen Herlyn and Julia Holle and Peter Lamprecht and Frank Moosig and Thomas Neumann and Jochen Zwerina and Gunnar T{\'o}masson and Pradeep Bambery and Ramesh Jois and Liza Rajasekhar and Aman Sharma and Rajappa Sivakumar and Eamonn Molloy and Philip Hashkes and Fausta Catapano and Luca Cimino and {De Fanti}, Alessandro and Nicolo Pipitone and Carlo Salvarani and Augusto Vaglio and Shigeto Kobayashi and Kazuo Suzuki and Flores-Su{\'a}rez, {Luis Felipe} and Andrea Hinojosa-Azaola and Elisabeth Brouwer and Abraham Rutgers and Coen Stegeman and Matteson, {Eric Lawrence} and Warrington, {Kenneth J} and Ytterberg, {Steven R}",
year = "2017",
month = "12",
day = "1",
doi = "10.3899/jrheum.161269",
language = "English (US)",
volume = "44",
pages = "1928--1932",
journal = "Journal of Rheumatology",
issn = "0315-162X",
publisher = "Journal of Rheumatology",
number = "12",

}

TY - JOUR

T1 - Assessment of disease activity in large-vessel vasculitis

T2 - Results of an international delphi exercise

AU - International Delphi on Disease Activity Assessment in Large-vessel Vasculitis

AU - Aydin, Sibel Z.

AU - Direskeneli, Haner

AU - Merkel, Peter A.

AU - Toloza, Sergio

AU - Blockmans, Daniel

AU - Sato, Emilia Inoue

AU - De Souza, Alexandre Wagner Silva

AU - Cabral, David

AU - Carette, Simon

AU - Famorca, Leilani

AU - Khalidi, Nader

AU - Milman, Nataliya

AU - Yacyshyn, Elaine

AU - Tesar, Vladimir

AU - Baslund, Bo

AU - Faurschou, Mikkel

AU - Guillevin, Loïc

AU - Puéchal, Xavier

AU - Aries, Peer

AU - Hellmich, Bernhard

AU - Herlyn, Karen

AU - Holle, Julia

AU - Lamprecht, Peter

AU - Moosig, Frank

AU - Neumann, Thomas

AU - Zwerina, Jochen

AU - Tómasson, Gunnar

AU - Bambery, Pradeep

AU - Jois, Ramesh

AU - Rajasekhar, Liza

AU - Sharma, Aman

AU - Sivakumar, Rajappa

AU - Molloy, Eamonn

AU - Hashkes, Philip

AU - Catapano, Fausta

AU - Cimino, Luca

AU - De Fanti, Alessandro

AU - Pipitone, Nicolo

AU - Salvarani, Carlo

AU - Vaglio, Augusto

AU - Kobayashi, Shigeto

AU - Suzuki, Kazuo

AU - Flores-Suárez, Luis Felipe

AU - Hinojosa-Azaola, Andrea

AU - Brouwer, Elisabeth

AU - Rutgers, Abraham

AU - Stegeman, Coen

AU - Matteson, Eric Lawrence

AU - Warrington, Kenneth J

AU - Ytterberg, Steven R

PY - 2017/12/1

Y1 - 2017/12/1

N2 - Objective. To arrive at consensus for candidate outcomes for disease activity assessment in largevessel vasculitis (LVV) in clinical trials. Methods.A Delphi survey including 99 items was circulated among international experts for 3 rounds. Results. Fifty-seven items were accepted for both giant cell arteritis and Takayasu arteritis. Sixty-seven percent of experts voted to have a common approach for both diseases with additional disease-specific items such as weight loss, scalp tenderness/necrosis, morning stiffness, dizziness, visual symptoms, and imaging. Conclusion. This study highlights similarities and differences in experts' perspectives for assessing clinical activity in LVV and may guide a consensus-driven core set of validated outcomes.

AB - Objective. To arrive at consensus for candidate outcomes for disease activity assessment in largevessel vasculitis (LVV) in clinical trials. Methods.A Delphi survey including 99 items was circulated among international experts for 3 rounds. Results. Fifty-seven items were accepted for both giant cell arteritis and Takayasu arteritis. Sixty-seven percent of experts voted to have a common approach for both diseases with additional disease-specific items such as weight loss, scalp tenderness/necrosis, morning stiffness, dizziness, visual symptoms, and imaging. Conclusion. This study highlights similarities and differences in experts' perspectives for assessing clinical activity in LVV and may guide a consensus-driven core set of validated outcomes.

KW - Giant cell arteritis

KW - Large vessel

KW - Outcomes

KW - Takayasu arteritis

KW - Vasculitis

UR - http://www.scopus.com/inward/record.url?scp=85037094161&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85037094161&partnerID=8YFLogxK

U2 - 10.3899/jrheum.161269

DO - 10.3899/jrheum.161269

M3 - Article

C2 - 28864648

AN - SCOPUS:85037094161

VL - 44

SP - 1928

EP - 1932

JO - Journal of Rheumatology

JF - Journal of Rheumatology

SN - 0315-162X

IS - 12

ER -